Corporate History

The Origin and Evolution of "Bai Jingyu"

　　According to the Bai family: its ancestors were the Hui, and they settled when Genghis Khan marched to the north bank of the Yellow River before the Yuan Dynasty. At the beginning of the 20th century, Bai Ruiqi, a descendant of the Bai family, inherited the three houses of his uncle, uncle, and father. He founded the "Golden Goat Eye Medicine Shop" under the name of his ancestor in the West Cross Street, Dingzhou City, Hebei Province. At that time, it was famous for its magical curative effect. According to legend, Emperor Qianlong of the Qing Dynasty made a close visit to the people. On the way, he contracted eye diseases suddenly, his eyes were red and swollen, painful and difficult to take the medicine, and the imperial doctor was unable to find the medicine shop opened by Bai's. except. Qianlong was overjoyed and immediately rewarded by the royal book "Jinyang Yaopu". Since then, Dingzhou Baijia's eye drops have become famous and widely circulated. Later, the people gave it an elegant name called "Universal Little Baiyan".

　　 In the early 1930s, Bai Ruiqi, the head of the Bai family, decided to open up the market in the south. He set up a Baijing Eye Medicine Shop at the entrance of Laofang Alley, Shengzhou Road, Nanjing, and then moved to No. 152 Baixia Road to officially open. After the outbreak of the Anti-Japanese War, business was once closed until it resumed business at No. 12, Zhuque Road, Nanjing in March 1938, and was renamed Nanjing Bai Jingyu Eye Medicine. In 1939, Bai Zemin, a descendant of the Bai family, changed the trademark "Golden Goat" to "Whale" in July. , The Whale trademark was granted a 20-year valid registration certificate issued by the National Government Trademark Office.

　　 In 1951, the head office moved from Hankou to Nanjing. It obtained the business license from the Commercial Bureau of Nanjing Municipal People's Government and the "Whale Trademark" registration certificate from the Private Enterprise Bureau of the Central People's Government, and was renamed Nanjing Baijingyu Pharmaceutical Factory.

　　 In September 1955, a public-private joint venture Nanjing Baijingyu Pharmaceutical Factory was formally established. Since then, more than a dozen small companies have merged with the Nanjing Baijingyu Pharmaceutical Factory in a public-private partnership, and have gradually developed into a comprehensive pharmaceutical company that produces raw materials and pharmaceutical preparations. Entering the mid-1990s, enterprises, like many state-owned enterprises, were caught in operational difficulties due to the slow pace of integrating with the market economy, and their profits declined year by year. By the end of the 1990s, enterprises had already put on the hat of loss. At that time, it coincided with the national economic operation difficulties, so the state proposed a series of policies for the reform of state-owned enterprises, such as "grasp the large and let go of the small", "three system reforms", etc., to promote the "privatization of small and medium state-owned enterprises." Separate the political, social, and other functions of the enterprise, and at the same time introduce the competition mechanism into the state-owned enterprise. In this situation, the company established a marketing company to make the last attempt to recover the loss. The marketing company stands at the forefront of the market and fully recognizes the importance of the brand, so it actively proposes to change the name of the "Nanjing Second Pharmaceutical Factory", which is deeply imprinted by the planned economy, to "Nanjing Baijingyu Pharmaceutical Factory". With many efforts, the application for name change was successfully applied in 2002, reinjecting the blood of time-honored brands into the company. Then the company responded to the government's call and completed the "three linkages" reform at the end of 2003. In January 2004, the company was restructured and formally established Nanjing Baijingyu Pharmaceutical Co., Ltd. At the same time, it responded to the municipal government's "retreat from two to three". The call was to relocate the production bases of raw materials and pharmaceutical preparations to Nanjing Chemical Industrial Park and Nanjing Economic and Technological Development Zone in 2004.